Arsenic Trioxide
Acytostatics, Aresenic Trioxide’s active ingredient leads to a fragmentation of the DNA, which then leads to apoptosis (cell death). It is predominantly used in the treatment of a subtype of blood cancer (APL).
Formula: As2O3
Molecular weight: 0.00 g/mol
Molecular size: Small
Controlled Substance: No
Precursor: No
Indications: Antineoplastic drugs
Status: Commercial
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827